You are here

Revolade

GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation

Wall St Cheat Sheet

Mon, 02/3/14 - 03:56 pm

breakthrough therapies

severe aplastic anemia

UK Glaxo Employee Blows Whistle On Drug Promotions

Pharmalot

Mon, 11/12/12 - 10:53 am

whistleblower lawsuits

Glaxo’s Revolade Fails to Win Recommendation of U.K. Agency

Bloomberg

Thu, 06/10/10 - 09:27 am

chronic immune thrombocytopenic purpura

Ligand Announces Approval for Revolade in Europe

Yahoo/BusinessWire

Sat, 03/13/10 - 10:00 am

thrombocytopenia

Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura

Pipeline Review

Sun, 12/20/09 - 10:54 am

Ligand Pharmaceuticals, GlaxoSmithKline blood disorder drug moves closer to European approval

Yahoo/AP

Fri, 12/18/09 - 10:34 am